UnitedHealth Raises 2026 Earnings Guidance After Q3 Results
UnitedHealth reported Q3 adjusted earnings of $4.69 per share and sales of $112.694 billion, both above consensus. It raised its 2026 adjusted earnings guidance to at least $20.50 per share and GAAP guidance to at least $19.50 per share.
15. 403 billion. 50 to $20. 86.
35 per share. “Our third quarter results reflect the discipline and execution our teams are bringing to every part of our business, as we continue evolving UnitedHealth Group to deliver a simpler, more supportive experience for patients and the clinicians who care for them,” said Stephen Hemsley, UnitedHealth Group’s chief executive officer. 04 on Wednesday. Baird analyst Michael Ha kept a Neutral rating on the stock and reduced his price target from $453 to $427.
Barclays analyst Andrew Mok maintained an Overweight rating and lowered his target from $441 to $440.